Provenienza dei contatti di primo grado di Svein Atle Roset
| Entità | Tipo di entità | Settore Industriale | |
|---|---|---|---|
| Public Company | Regional Banks | 8 |
Grafico delle società connesse in secondo grado
Relazione in diverse aziende
Società connesse a Svein Atle Roset tramite i suoi contatti personali
| Società | Settore | Persone collegate | Posizione principale |
|---|---|---|---|
Xpro AS
 Xpro AS Miscellaneous Commercial ServicesCommercial Services Part of AFRY AB, Xpro AS is a Norwegian company that is currently developing a next-generation selective inhibitor of tumor necrosis factor (TNF) called xpro™. The company is based in Molde, Norway. The drug is currently in clinical trials and has the potential to decrease neuroinflammation, neurodegeneration, and promote remyelination in patients with neurologic disease by neutralizing soluble TNF. The company was founded in 2016. The CEO is Vegard Storvik. | Miscellaneous Commercial Services | Chairman |
Statistiche
Distribuzione geografica
| Norvegia | 3 |
Settori
| Process Industries | 2 |
| Commercial Services | 2 |
Posizioni
| Director/Board Member | 6 |
| Chairman | 2 |
| Corporate Officer/Principal | 1 |
| Compliance Officer | 1 |
Contatti più connessi
- Borsa valori
- Insiders
- Svein Atle Roset
- Connessioni Società
